One thing I do notice with AZV is it is tightly held.Top 20 own about 80%.It still looks under valued given what we know by way of earnings.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025